Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.90M | 0.00 | 115.60M | 125.50M | 119.50M | 125.50M |
Gross Profit | 27.70M | -500.00K | 31.00M | 36.70M | 28.10M | 34.90M |
EBITDA | 24.10M | 21.50M | 49.20M | 59.30M | 47.60M | 52.80M |
Net Income | -10.70M | -100.00K | -20.20M | -10.50M | 6.80M | 500.00K |
Balance Sheet | ||||||
Total Assets | 37.20M | 37.40M | 180.10M | 821.90M | 814.50M | 810.70M |
Cash, Cash Equivalents and Short-Term Investments | 300.00K | 700.00K | 100.00K | 12.00M | 10.90M | 10.10M |
Total Debt | 14.10M | 14.10M | 14.10M | 413.30M | 402.20M | 393.40M |
Total Liabilities | 15.40M | 14.20M | 15.00M | 572.80M | 595.70M | 592.70M |
Stockholders Equity | 21.80M | 23.20M | 165.10M | 249.10M | 218.80M | 218.00M |
Cash Flow | ||||||
Free Cash Flow | -12.00M | 100.00K | -9.90M | 5.70M | -5.80M | -33.70M |
Operating Cash Flow | 5.70M | 100.00K | 30.80M | 46.10M | 36.10M | 37.90M |
Investing Cash Flow | 41.50M | 1.60M | 17.70M | -36.60M | -33.30M | -63.80M |
Financing Cash Flow | -61.20M | -1.10M | -60.40M | -8.40M | -2.00M | 18.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £52.56B | 17.19 | 8.35% | 4.45% | -7.42% | 5.84% | |
71 Outperform | £19.73B | 16.58 | 12.29% | 3.58% | -3.11% | -31.10% | |
67 Neutral | £7.98B | 30.15 | 13.05% | 4.44% | 10.04% | ― | |
61 Neutral | £7.32B | 5.62 | 11.07% | 5.18% | 4.13% | -72.10% | |
58 Neutral | £2.32B | ― | -4.44% | 6.93% | 15.42% | -406.43% | |
57 Neutral | £7.89B | 34.21 | 12.73% | 4.65% | 3.78% | 50.18% | |
54 Neutral | ― | 6.08% | ― | ― |